Cathie Wood Galmed Pharmaceuticals Ltd. Transaction History

Ark Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$3.46 - $5.69 $803,315 - $1.32 Million	-232,172 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$3.22 - $6.08 $463,451 - $875,088	143,929 Added 163.11%	232,172 $1.11 Million
Q1 2020 May 14, 2020	SELL	$3.3 - $6.84 $8,266 - $17,134	-2,505 Reduced 2.76%	88,243 $305,000
Q4 2019 Jan 31, 2020	BUY	$3.61 - $6.75 $65,532 - $122,532	18,153 Added 25.01%	90,748 $525,000
Q3 2019 Nov 12, 2019	BUY	$4.62 - $7.11 $53,809 - $82,810	11,647 Added 19.11%	72,595 $347,000

Q2 2019 Jul 30, 2019	BUY	$5.68 - $8.68 $40,890 - $62,487	7,199 Added 13.39%	60,948 $448,000
Q1 2019 May 13, 2019	BUY	$7.27 - $9.07 $93,819 - $117,048	12,905 Added 31.6%	53,749 $439,000
Q4 2018 Feb 01, 2019	BUY	$6.59 - $14.47 $32,936 - $72,321	4,998 Added 13.94%	40,844 $279,000
Q3 2018 Nov 07, 2018	BUY	$10.55 - $15.28 $378,175 - $547,726	35,846 New	35,846 $487,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.53M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.